The U.S. Food and Drug Administration Approves Pirtobrutinib (Jaypirca) for Relapsed/Refractory Mantle Cell Lymphoma
On January 27, 2023 the U.S. Food and Drug Administration (FDA) announced it has approved pirtobrutinib…
On January 27, 2023 the U.S. Food and Drug Administration (FDA) announced it has approved pirtobrutinib…
On January 19, the U.S. Food and Drug Administration (FDA) announced it has approved bruton tyrosine…
On December 22, 2022, the U.S. Food and Drug Administration (FDA) announced it has approved…
December 23, 2022 – It is with great sadness that the Lymphoma Research Foundation (LRF)…
No parent should ever have to go through the excruciating experience of losing a child.…
Roy Bridges has the type of life story you need to read to believe. Starting…
Where Are They Now? Paolo Strati, MD When did you become interested in the study…